Efficacy and Safety of XC8, Film-coated Tablets, 40 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection

Clinical trial NCT05273619 · COMPLETED

Trial details

NCT number: NCT05273619
Sponsor: Valenta Pharm JSC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Common Cold Acute Respiratory Infection Influenza, Human

Start date: 2022-05-23
Primary completion: 2022-07-13
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.